Simulation of Left Atrial Function Using a Multi-Scale Model of the Cardiovascular SystemPironet, Antoine ; Dauby, Pierre ; Paeme, Sabine et alin PLoS ONE (2013), 8(6), 65146 During a full cardiac cycle, the left atrium successively behaves as a reservoir, a conduit and a pump. This complex behavior makes it unrealistic to apply the time-varying elastance theory to ... [more ▼] During a full cardiac cycle, the left atrium successively behaves as a reservoir, a conduit and a pump. This complex behavior makes it unrealistic to apply the time-varying elastance theory to characterize the left atrium, first, because this theory has known limitations, and second, because it is still uncertain whether the load independence hypothesis holds. In this study, we aim to bypass this uncertainty by relying on another kind of mathematical model of the cardiac chambers. In the present work, we describe both the left atrium and the left ventricle with a multi-scale model. The multi-scale property of this model comes from the fact that pressure inside a cardiac chamber is derived from a model of the sarcomere behavior. Macroscopic model parameters are identified from reference dog hemodynamic data. The multi-scale model of the cardiovascular system including the left atrium is then simulated to show that the physiological roles of the left atrium are correctly reproduced. This include a biphasic pressure wave and an eight-shaped pressure-volume loop. We also test the validity of our model in non basal conditions by reproducing a preload reduction experiment by inferior vena cava occlusion with the model. We compute the variation of eight indices before and after this experiment and obtain the same variation as experimentally observed for seven out of the eight indices. In summary, the multi-scale mathematical model presented in this work is able to correctly account for the three roles of the left atrium and also exhibits a realistic left atrial pressure-volume loop. Furthermore, the model has been previously presented and validated for the left ventricle. This makes it a proper alternative to the time-varying elastance theory if the focus is set on precisely representing the left atrial and left ventricular behaviors. [less ▲] Detailed reference viewed: 5 (4 ULg) Evaluation of a Model-Based Hemodynamic Monitoring Method in a Porcine Study of Septic Shock; ; et al in Computational and Mathematical Methods in Medicine (2013) Detailed reference viewed: 12 (2 ULg) A Multi‐Scale Computer Model of the Cardiovascular System Can Account for the Three Roles of the Left AtriumPironet, Antoine ; Dauby, Pierre ; Kosta, Sarah et alin Abstract Book GIGA-Day (2013, January 28) Detailed reference viewed: 38 (9 ULg) A Multi‐Scale Computer Model of the Cardiovascular System Can Account for the Three Roles of the Left AtriumPironet, Antoine ; Dauby, Pierre ; Kosta, Sarah et alPoster (2013, January 28) Detailed reference viewed: 22 (11 ULg) Model-based glycemic control in critical carePretty, Christopher ; Penning, Sophie ; et alPoster (2012, December) Detailed reference viewed: 18 (4 ULg) Insulin clearance during hyper-insulinemia euglycemia therapyPenning, Sophie ; MASSION, Paul ; Pretty, Christopher et alin Proceedings of the 11th Belgian Day on Biomedical Engineering (2012, December) Detailed reference viewed: 14 (10 ULg) Insulin clearance during hyper-insulinemia euglycemia therapyPenning, Sophie ; MASSION, Paul ; Pretty, Christopher et alPoster (2012, December) Detailed reference viewed: 22 (11 ULg) Cumulative time in band (cTIB): glycemic level, variability and patient outcome all in onePenning, Sophie ; ; et alConference (2012, October 15) Detailed reference viewed: 22 (1 ULg) Cumulative Time in Band (cTIB): Glycemic Level, Variability and Patient Outcome All in 1Penning, Sophie ; ; et alin Intensive Care Medicine (2012, October), 38 (Suppl 1) Detailed reference viewed: 21 (1 ULg) Second pilot trials of the STAR-Liege protocol for tight glycemic control in critically ill patientsPenning, Sophie ; ; MASSION, Paul et alin BioMedical Engineering OnLine (2012) Detailed reference viewed: 18 (3 ULg) structural model of the mitral valve included in a cardiovascular closed loop model. Static and dynamic validationPaeme, Sabine ; Pironet, Antoine ; et alConference (2012, August 31) Detailed reference viewed: 7 (3 ULg) Structural model of the mitral valve included in a cardiovascular closed loop model. Static and dynamic validationPaeme, Sabine ; Pironet, Antoine ; et alin proceedings of 8th IFAC Symposium on Biological and Medical Systems, Budapest 29-31 août 2012 (2012, August 31) Detailed reference viewed: 20 (3 ULg) Interstitial kinetic parameters for a 2-compartment insulin model with saturable clearancePretty, Christopher ; ; et alConference (2012, August) Detailed reference viewed: 24 (1 ULg) Impact of sensor and measurement timing errors on model-based insulin sensitivityPretty, Christopher ; ; et alConference (2012, August) Detailed reference viewed: 1 (0 ULg) Interstitial kinetic parameters for a 2-compartment insulin model with saturable clearancePretty, Christopher ; ; et alin Proceedings of the 8th IFAC Symposium on Biological and Medical Systems (2012, August) Detailed reference viewed: 2 (0 ULg) Impact of sensor and measurement timing errors on model-based insulin sensitivityPretty, Christopher ; ; et alin Proceedings of the 8th IFAC Symposium on Biological and Medical Systems (2012, August) Detailed reference viewed: 3 (1 ULg) Insulin Kinetics during Hyper-Insulinemia Euglycemia Therapy (HIET)Penning, Sophie ; MASSION, Paul ; et alin Proceedings of the 8th IFAC Symposium on Biological and Medical Systems (2012, August) Hyper-insulinemia euglycemia therapy (HIET) is a supra-physiological insulin dosing protocol used in acute cardiac failure to reduce dependency on inotropes to augment or generate cardiac output, and is ... [more ▼] Hyper-insulinemia euglycemia therapy (HIET) is a supra-physiological insulin dosing protocol used in acute cardiac failure to reduce dependency on inotropes to augment or generate cardiac output, and is based on the inotropic effects of insulin at high doses up to 45-250x normal daily dose. Such high insulin doses are managed using intravenous glucose infusion to control glycemia and prevent hypoglycemia. However, both insulin dosing and glycemic control in these patients is managed ad-hoc. This research examines a selection of clinical data to determine the effect of high insulin dosing on renal clearance and insulin sensitivity, to assess the feasibility of using model-based methods to control and guide these protocols. The results show that the model and, in particular, the modeled renal clearance constant are adequate and capture measured data well, although not perfectly. Equally, insulin sensitivity over time is similar to broader critical care cohorts in level and variability, and these results are the first time they have been presented for this cohort. While more data is needed to confirm and further specify these results, it is clear that the model used is adequate for controlling HIET in a model-based framework. [less ▲] Detailed reference viewed: 16 (5 ULg) Insulin Kinetics during Hyper-Insulinemia Euglycemia Therapy (HIET)Penning, Sophie ; MASSION, Paul ; et alConference (2012, August) Detailed reference viewed: 15 (3 ULg) Development and Pilot Trial Results of Stochastic Targeted (STAR) Glycemic Control in a Medical ICU; ; et al in Proceedings of the 8th IFAC Symposium on Biological and Medical Systems (2012, August) Detailed reference viewed: 15 (2 ULg) Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic controlPretty, Christopher ; ; et alin Annals of Intensive Care (2012) Introduction: Effective tight glycaemic control (TGC) can improve outcomes in critical care patients, but is difficult to achieve consistently. Insulin sensitivity defines the metabolic balance between ... [more ▼] Introduction: Effective tight glycaemic control (TGC) can improve outcomes in critical care patients, but is difficult to achieve consistently. Insulin sensitivity defines the metabolic balance between insulin concentration and insulin mediated glucose disposal. Hence, variability of insulin sensitivity can cause variable glycaemia. This study quantifies and compares the daily evolution of insulin sensitivity level and variability for critical care patients receiving TGC. <br /> <br />Methods: A retrospective analysis of data from the SPRINT TGC study involving patients admitted to a mixed medical-surgical ICU between August 2005 and May 2007. Only patients who commenced TGC within 12 hours of ICU admission and spent at least 24 hours on the SPRINT protocol were included (N=164). Model-based insulin sensitivity (SI) was identified each hour. Absolute level and hour-to-hour percent changes in SI were assessed on cohort and per-patient bases. Levels and variability of SI were compared over time on 24-hour and 6-hour timescales for the first 4 days of ICU stay. <br /> <br />Results: Cohort and per-patient median SI levels increased by 34% and 33% (p<0.001) between days 1 and 2 of ICU stay. Concomitantly, cohort and per-patient SI variability decreased by 32% and 36% (p<0.001). For 72% of the cohort, median SI on day 2 was higher than on day 1. The day 1-2 results are the only clear, statistically significant trends across both analyses. <br /> <br />Analysis of the first 24 hours using 6-hour blocks of SI data showed that most of the improvement in insulin sensitivity level and variability seen between days 1 and 2 occurred during the first 12-18 hours of day 1. <br /> <br />Conclusions: Critically ill patients have significantly lower and more variable insulin sensitivity on day 1 than later in their ICU stay and particularly during the first 12 hours. This rapid improvement is likely due to the decline of counter-regulatory hormones as the acute phase of critical illness progresses. Clinically, these results suggest that while using TGC protocols with patients during their first few days of ICU stay, extra care should be afforded. Increased measurement frequency, higher target glycaemic bands, conservative insulin dosing and modulation of carbohydrate nutrition should be considered to safely minimize outcome glycaemic variability and reduce the risk of hypoglycaemia. [less ▲] Detailed reference viewed: 32 (18 ULg) |
||